Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 01:28PM ET
2.50
Dollar change
-0.34
Percentage change
-11.97
%
Index- P/E- EPS (ttm)-0.29 Insider Own26.90% Shs Outstand9.44M Perf Week34.41%
Market Cap23.83M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.30M Perf Month-2.35%
Income-2.40M PEG- EPS next Q- Inst Own4.70% Short Float0.04% Perf Quarter-
Sales- P/S- EPS this Y0.00% Inst Trans- Short Ratio0.01 Perf Half Y-
Book/sh1.07 P/B2.34 EPS next Y- ROA-34.20% Short Interest0.00M Perf Year-
Cash/sh0.00 P/C- EPS next 5Y- ROE-46.90% 52W Range1.42 - 4.98 Perf YTD-14.97%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-49.80% Beta-
Dividend TTM- Quick Ratio0.10 Sales past 5Y- Gross Margin100.00% 52W Low76.06% ATR (14)0.60
Dividend Ex-Date- Current Ratio0.10 EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility38.90% 22.05%
Employees7 Debt/Eq0.26 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.12 EPS Q/Q- Payout0.00% Rel Volume0.64 Prev Close2.84
Sales Surprise- EPS Surprise- Sales Q/Q-68.90% Earnings- Avg Volume119.74K Price2.50
SMA2020.95% SMA5014.56% SMA20014.56% Trades Volume48,594 Change-11.97%
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.